Ocuphire Pharma shares fall on appointment of interim CEO
21/04/2023 16:02
** Shares of biopharmaceutical company Ocuphire Pharma
OCUP.O down 21.9% at $4.81
** Co appoints Rick Rodgers as interim CEO, succeeding Mina
Sooch
** Co retains executive search firm to assist in identifying
a permanent CEO
** OCUP shares up 39% YTD, as of last close
(Reporting by Tanya Jain)
((Tanya.Jain@thomsonreuters.com))
Recent news on Opus Genetics
See all newsUS RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
Health Rounds: Experimental eye drops ease night vision problems for drivers
U.S. STOCKS ON THE MOVE-Apple, Omnicom, Jersey Mike's Subs
U.S. STOCKS ON THE MOVE-Airbnb, Lyft, Korn Ferry
Opus Genetics hits 5-year high on positive early- to mid-stage eye disease gene therapy data